| 1 |
breast cancer resistance protein
(1308 times)
|
Pharmacology
(498 times)
|
P-gp (508 times)
ABC (174 times)
MRP2 (119 times)
|
1998 A multidrug resistance transporter from human MCF-7 breast cancer cells.
|
| 2 |
breast cancer-related protein
(8 times)
|
Medicine
(2 times)
|
P-gp (4 times)
ABC (2 times)
BBB (2 times)
|
2006 Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies.
|
| 3 |
BCRP/MXR/ABCP
(2 times)
|
Neoplasms
(2 times)
|
---
|
2001 Identification of breast cancer resistant protein/mitoxantrone resistance/placenta-specific, ATP-binding cassette transporter as a transporter of NB-506 and J-107088, topoisomerase I inhibitors with an indolocarbazole structure.
|
| 4 |
breast cancer receptor protein
(2 times)
|
Pharmacology
(2 times)
|
ABC (1 time)
AP (1 time)
app (1 time)
|
2007 Transport and metabolism of MitoQ10, a mitochondria-targeted antioxidant, in Caco-2 cell monolayers.
|
| 5 |
Breast Cancer Research Program
(2 times)
|
Gynecology
(1 time)
|
BC (1 time)
BCRF (1 time)
DoD (1 time)
|
2005 Perspective from the Department of Defense Breast Cancer Research Program.
|
| 6 |
Baltimore Cancer Research Program
(1 time)
|
Neoplasms
(1 time)
|
ANLL (1 time)
|
1987 Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival.
|
| 7 |
BCRP substrates
(1 time)
|
Molecular Biology
(1 time)
|
Fni,7.0 (1 time)
fup (1 time)
GMFE (1 time)
|
2022 Developing an In Vitro to In Vivo Extrapolation (IVIVE) Model to Predict Human Milk-to-Plasma Drug Concentration Ratios.
|
| 8 |
benign colorectal polyps
(1 time)
|
Neoplasms
(1 time)
|
CRC (1 time)
NPV (1 time)
PPV (1 time)
|
2022 The role of microvesicles as biomarkers in the screening of colorectal neoplasm.
|
| 9 |
Boston Combined Residency Program
(1 time)
|
Clinical Medicine
(1 time)
|
UIM (1 time)
|
2022 Implementing and Assessing a Resident Diversity Council to Address the Need for a Diverse Clinical Workforce.
|
| 10 |
Breakpoint Cluster Region pseudogene
(1 time)
|
Genetics, Medical
(1 time)
|
22q11.2DS (1 time)
Mb (1 time)
WGS (1 time)
|
2016 Variant discovery and breakpoint region prediction for studying the human 22q11.2 deletion using BAC clone and whole genome sequencing analysis.
|
| 11 |
Breast Cancer Resistance Peptide
(1 time)
|
Pharmacy
(1 time)
|
---
|
2010 ABCG2 polymorphisms, 34G>A and 421C>A in a Korean population: analysis and a comprehensive comparison with other populations.
|
| 12 |
breast cancer resistance protein substrate
(1 time)
|
Pharmacology
(1 time)
|
AUC (1 time)
EGFR (1 time)
GLSM (1 time)
|
2018 Effect of multiple-dose osimertinib on the pharmacokinetics of simvastatin and rosuvastatin.
|
| 13 |
Breast cancer risk perception
(1 time)
|
Public Health
(1 time)
|
BCRAF (1 time)
GRM (1 time)
|
2017 A Risk Assessment Comparison of Breast Cancer and Factors Affected to Risk Perception of Women in Turkey: A Cross-sectional Study.
|
| 14 |
breast cancer therapy-resistant protein
(1 time)
|
Biochemistry
(1 time)
|
5'-RACE (1 time)
5-FU (1 time)
DPYD (1 time)
|
2020 Tivantinib Decreases Hepatocyte Growth Factor-Induced BCRP Expression in Hepatocellular Carcinoma HepG2 Cells.
|
| 15 |
bromocriptine-resistant prolactinomas
(1 time)
|
Neurology
(1 time)
|
ER (1 time)
WIF1 (1 time)
|
2013 Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas.
|
A Search Service for Abbreviation / Long Form